BPMC Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BPMC shares is 433, representing 106.41% of the company's common stock.

ASSENAGON ASSET MANAGEMENT S.A., in the last quarter, reduced its stake in BPMC by -35.06% restricting it's holding to 175.11 thousand shares of worth nearly $16.61M. UBS GROUP AG also lessened -0.87% of the BPMC shares from its portfolio, reducing its holding to 125.44 thousand shares of worth $11.90M. CITIGROUP INC also shunned BPMC shares holding by -41.86% last quarter which brought its holding to 103.86 thousand shares worth $9.85M.

As per its latest 13F filing, VICTORY CAPITAL MANAGEMENT INC increased its stake in BPMC by 57.34% in the last quarter. The institutional holder raised its holding to 206.2 thousand shares having worth more than $19.56M. INTEGRAL HEALTH ASSET MANAGEMENT, LLC also added 50% more shares of BPMC to its portfolio, raising its holding to 210 thousand shares of worth $19.92M. MANUFACTURERS LIFE INSURANCE COMPANY, THE also increased its BPMC shares holding by 35.49% which brought its holding to 184.22 thousand shares worth $17.48M.

The insider with the most stakes in BPMC is Albers Jeffrey W. , director at the company. Additionally, BPMC stock is highly held by CHIEF EXECUTIVE OFFICER Haviland Kate and PRESIDENT, R & D Namouni Fouad among others.

Company executives, directors, and other insiders own 0.92% percent of Blueprint Medicines Corporation's stock. Within the last six months, there have been 17 transaction(s) in which BPMC insiders have sold stock, totaling 103.61K shares. Insiders that have sold shares include NAMOUNI FOUAD, ALBERS JEFFREY W., and LANDSITTEL MICHAEL.

There have been 0 transaction(s) during the past 6-months in which Blueprint Medicines Corporation insiders have bought stock, totalling 0 shares

Around 838.45K Blueprint Medicines Corporation shares are held by insiders, which represents about 0.92% of BPMC stock.

BPMC director, Albers Jeffrey W. holds the largest portfolio of the company's shares. BPMC shares owned by Albers total nearly 157.56 thousand.

VICTORY CAPITAL MANAGEMENT INC is the largest institutional owner in BPMC which holds 206.2 thousand shares worth $19.56M or 0.34% of the total BPMC shares outstanding followed by INTEGRAL HEALTH ASSET MANAGEMENT, LLC with ownership of 210 thousand shares representing 0.35% of the BPMC ownership. MANUFACTURERS LIFE INSURANCE COMPANY, THE is the third largest stakeholder with 184.22 thousand shares or 0.3% of the ownership worth more than $17.48M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BPMC is concerned, it is a stock which is optionable.

Number of BPMC shares short is 3.53M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 63.35M shares of BPMC are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BPMC has 62.65M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BPMC is 5.26.